Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's After-Market Session

Author: Benzinga Insights | March 04, 2024 05:32pm

Gainers

  • Vicarious Surgical (NYSE:RBOT) shares moved upwards by 24.9% to $0.45 during Monday's after-market session. The company's market cap stands at $78.6 million. As per the news, the Q4 earnings report came out today.
  • Ekso Bionics Holdings (NASDAQ:EKSO) stock increased by 21.42% to $2.55. The company's market cap stands at $45.4 million. The company's, Q4 earnings came out today.
  • Jaguar Health (NASDAQ:JAGX) shares moved upwards by 20.48% to $0.17. The market value of their outstanding shares is at $8.7 million.
  • Sunshine Biopharma (NASDAQ:SBFM) stock rose 11.35% to $0.05. The company's market cap stands at $2.7 million.
  • Protara Therapeutics (NASDAQ:TARA) stock increased by 11.12% to $4.89. The company's market cap stands at $55.5 million.
  • Talphera (NASDAQ:TLPH) shares moved upwards by 6.15% to $1.38. The company's market cap stands at $23.3 million.

Losers

  • Cara Therapeutics (NASDAQ:CARA) shares decreased by 15.0% to $0.85 during Monday's after-market session. The company's market cap stands at $46.3 million. As per the news, the Q4 earnings report came out today.
  • Moleculin Biotech (NASDAQ:MBRX) shares decreased by 14.25% to $0.59. The market value of their outstanding shares is at $19.7 million.
  • Tandem Diabetes Care (NASDAQ:TNDM) shares decreased by 9.13% to $28.3. The market value of their outstanding shares is at $1.8 billion.
  • Ocean Biomedical (NASDAQ:OCEA) stock fell 8.83% to $3.72. The company's market cap stands at $126.8 million.
  • Stereotaxis (AMEX:STXS) stock declined by 7.67% to $2.41. The market value of their outstanding shares is at $194.9 million. As per the press release, Q4 earnings came out today.
  • Avadel Pharmaceuticals (NASDAQ:AVDL) stock declined by 7.63% to $14.9. The market value of their outstanding shares is at $1.3 billion. The company's, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVDL CARA EKSO JAGX MBRX OCEA RBOT SBFM STXS TARA TLPH TNDM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist